{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:08:50Z","timestamp":1791994130601,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.ejogrb.2011.07.005","type":"journal-article","created":{"date-parts":[[2011,8,13]],"date-time":"2011-08-13T15:03:43Z","timestamp":1313247823000},"page":"127-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Clinical, endocrine and metabolic effects of metformin vs N-acetyl-cysteine in women with polycystic ovary syndrome"],"prefix":"10.1016","volume":"159","author":[{"given":"Gokalp","family":"Oner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iptisam Ipek","family":"Muderris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2011.07.005_bib0005","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/09513599809015601","article-title":"Insulin and polycystic ovary syndrome: a new look at an old subject","volume":"12","author":"Ciampelli","year":"1998","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0015","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejogrb.2006.10.037","article-title":"Is the polycystic ovary syndrome associated with chronic inflammation per se?","volume":"133","author":"Olszanecka-Glinianowicz","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1463-1326.1999.00026.x","article-title":"The polycystic ovary syndrome: treatment with insulin sensitizing agents","volume":"1","author":"Iuorno","year":"1999","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0030","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1210\/jc.2005-0694","article-title":"Hyperglycemia alters tumor necrosis factor-alpha release from mononuclear cells in women with polycystic ovary syndrome","volume":"90","author":"Gonz\u00e1lez","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"29","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0040","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1056\/NEJM199806253382603","article-title":"Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome","volume":"338","author":"Nestler","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0045","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy","volume":"43","author":"Velazquez","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0050","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0029-7844(97)00296-2","article-title":"Menstrual cyclicity after metformin therapy in polycystic ovary syndrome","volume":"90","author":"Vel\u00e1zquez","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0055","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0015-0282(00)00501-X","article-title":"Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome","volume":"73","author":"Kolodziejczyk","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0060","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.327.7421.951","article-title":"Metformin in polycystic ovary syndrome: systematic review and meta-analysis","volume":"327","author":"Lord","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0065","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/humrep\/dem005","article-title":"Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review","volume":"22","author":"Costello","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0070","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0015-0282(02)03133-3","article-title":"N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome","volume":"77","author":"Fulghesu","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0075","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijgo.2004.03.002","article-title":"N-acetyl-cysteine treatment for polycystic ovary syndrome","volume":"85","author":"Kilic-Okman","year":"2004","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0080","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.fertnstert.2004.07.960","article-title":"N-acetyl-cysteine is a novel adjuvant to clomiphene citrate in clomiphene citrate-resistant patients with polycystic ovary syndrome","volume":"83","author":"Rizk","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00005344-199807000-00016","article-title":"Oral administration of the antioxidant, N-acetylcysteine, abrogates diabetes-induced endothelial dysfunction","volume":"32","author":"Pieper","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0090","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.fertnstert.2006.11.173","article-title":"N-acetyl cysteine vs. metformin in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective randomized controlled study","volume":"88","author":"Elnashar","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0095","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0100","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","article-title":"Ultrasound assessment of the polycystic ovary: international consensus definitions","volume":"9","author":"Balen","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0105","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1210\/jc.2003-030424","article-title":"Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome","volume":"88","author":"Harborne","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0110","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9378(81)90746-8","article-title":"Hirsutism: implications, etiology, and management","volume":"140","author":"Hatch","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0115","doi-asserted-by":"crossref","unstructured":"ACOG Committee on Practice Bulletins \u2013 Gynecology. ACOG Practice Bulletin No. 108: Polycystic ovary syndrome. Obstet Gynecol 2009;114:936-49.","DOI":"10.1097\/AOG.0b013e3181bd12cb"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/gye.17.1.51.56","article-title":"Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome","volume":"17","author":"Kazerooni","year":"2003","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0125","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/1479164109336050","article-title":"Long-term effect of metformin on metabolic parameters in the polycystic ovary syndrome","volume":"6","author":"Cheang","year":"2009","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0130","first-page":"139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0135","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/humrep\/dei311","article-title":"Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study","volume":"21","author":"Tang","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0140","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1210\/jc.2008-0461","article-title":"The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials","volume":"93","author":"Hoeger","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0145","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0015-0282(01)02963-6","article-title":"Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome","volume":"77","author":"Nestler","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(02)04554-5","article-title":"A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome","volume":"79","author":"Costello","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0155","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1093\/humrep\/deh440","article-title":"Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome","volume":"19","author":"Kashyap","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0160","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1073\/pnas.91.11.4854","article-title":"Tumor necrosis factor alpha inhibits signaling from the insulin receptor","volume":"91","author":"Hotamisligil","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0165","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0026-0495(99)90100-2","article-title":"Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome","volume":"48","author":"Gonzalez","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0170","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1677\/jme.1.02061","article-title":"Metformin reduces lipolysis in primary rat adipocytes stimulated by tumor necrosis factor-alpha or isoproterenol","volume":"37","author":"Ren","year":"2006","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.ejogrb.2011.07.005_bib0175","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2217\/17455057.3.1.73","article-title":"Obesity management in women with polycystic ovary syndrome","volume":"3","author":"Lim","year":"2007","journal-title":"Womens Health (Lond Engl)"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121151100426X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121151100426X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:25:55Z","timestamp":1759555555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030121151100426X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S030121151100426X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2011.07.005","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical, endocrine and metabolic effects of metformin vs N-acetyl-cysteine in women with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2011.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}